-
HPA014179-25UL
ANTI-LXN
Price: $540.00List Price: $600.00The gene LXN (latexin) encodes a 222-residue that contains two topologically equivalent subdomains with an α-helix surrounded by a curved β-sheet. A third α-helix forms a connection linking the subdomains. -
HPA022040-25UL
ANTI-RUNX2
Price: $540.00List Price: $600.00Runt-related transcription factor 2/acute myeloid leukemia 3 protein (RUNX2, AML-3) belongs to Runt DNA-binding domain transcription factor family. RUNX2 gene is mapped to human chromosome 6p21. -
1191554-30MG
Didymin
Price: $1,829.67List Price: $2,032.97This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the -
BP823
Doxepin impurity standard
Price: $403.79List Price: $448.65This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1225511-50MG
Doxepin Related Compound A
Price: $2,835.16List Price: $3,150.18This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1225522-50MG
Doxepin Related Compound B
Price: $2,274.73List Price: $2,527.47This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1225533-25MG
Doxepin Related Compound C
Price: $2,274.73List Price: $2,527.47This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the